Juan‐Carlos Lopez‐Talavera

HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN

L. Viladomiu, Antonio González, M Roget et al. · The Lancet · 1989 · 900 citations

Life Sciences, Immunology, Infectious Diseases +8

Transgenic Overexpression of Hepatocyte Growth Factor in the β-Cell Markedly Improves Islet Function and Islet Transplant Outcomes in Mice

Adolfo Garcı́a-Ocaña, Rupangi C. Vasavada, Ana Cebrián et al. · Diabetes · 2001 · 158 citations · Full text

Medicine, Endocrinology, Molecular Biology +17

Adenovirus-mediated Hepatocyte Growth Factor Expression in Mouse Islets Improves Pancreatic Islet Transplant Performance and Reduces Beta Cell Death

Adolfo Garcı́a-Ocaña, Karen K. Takane, Vasumathi T. Reddy et al. · Journal of Biological Chemistry · 2002 · 121 citations · Full text

Medicine, Endocrinology, Molecular Biology +15

Derivation of Phase 3 dosing for peginterferon lambda‐1a in chronic hepatitis C, Part 2: Exposure–response analyses for efficacy and safety variables

Matthew Hruska, Xiaodong Wang, Phyllis Chan et al. · The Journal of Clinical Pharmacology · 2014 · 10 citations

Pharmacy, Pharmacokinetics, Pharmacology +17